Testafeme 10 mg Cream.
PDF Leaflet Revision Date: 31 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of hypoactive sexual desire dysfunction in postmenopausal women.
Dosage (summary)
Starting dose: 5 mg (0.5 ml) daily; may increase to 10 mg (1 ml) if no improvement in 3 months.
Onset of Action / Duration
Onset: 4-8 weeks, Duration: up to 6 months.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; potential for virilization of a female fetus.
Key Drug Interactions
- Oral oestrogens
- Glucocorticoids
- Anticoagulants
- Bupropion
- Ciclosporin
Contraindications
- Known sensitivity to testosterone
- Carcinoma of the breast
- Androgen-dependent neoplasia
- Nephrotic syndrome
- History of thromboembolism
- Hypercalcaemia
Common side effects
- Acne
- Increased hair growth
- Alopecia
- Voice change
- Headache
Counselling Points
- Wash hands after application
- Avoid contact with application site
- Monitor for signs of virilization
Serious warnings
- Monitor for androgenic side effects
- Risk of transfer to others
- Caution in cardiovascular disease
Important Disclaimer
The Testafeme 10 mg Cream. professional information leaflet below is the property of Pharmacorp and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
